What is the official website of SEQENS Pharmaceutical Solutions ?

The official website of SEQENS Pharmaceutical Solutions is https://cdmo.seqens.com.

What is SEQENS Pharmaceutical Solutions's cybersecurity risk score?

SEQENS Pharmaceutical Solutions has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has SEQENS Pharmaceutical Solutions experienced?

According to Rankiteo, SEQENS Pharmaceutical Solutions currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has SEQENS Pharmaceutical Solutions been affected by any supply chain cyber incidents ?

According to Rankiteo, SEQENS Pharmaceutical Solutions has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does SEQENS Pharmaceutical Solutions have SOC 2 Type 1 certification ?

According to Rankiteo, SEQENS Pharmaceutical Solutions is not certified under SOC 2 Type 1.

Does SEQENS Pharmaceutical Solutions have SOC 2 Type 2 certification ?

According to Rankiteo, SEQENS Pharmaceutical Solutions does not hold a SOC 2 Type 2 certification.

Does SEQENS Pharmaceutical Solutions comply with GDPR ?

According to Rankiteo, SEQENS Pharmaceutical Solutions is not listed as GDPR compliant.

Does SEQENS Pharmaceutical Solutions have PCI DSS certification ?

According to Rankiteo, SEQENS Pharmaceutical Solutions does not currently maintain PCI DSS compliance.

Does SEQENS Pharmaceutical Solutions comply with HIPAA ?

According to Rankiteo, SEQENS Pharmaceutical Solutions is not compliant with HIPAA regulations.

Does SEQENS Pharmaceutical Solutions have ISO 27001 certification ?

According to Rankiteo,SEQENS Pharmaceutical Solutions is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does SEQENS Pharmaceutical Solutions operate in ?

SEQENS Pharmaceutical Solutions operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does SEQENS Pharmaceutical Solutions have ?

SEQENS Pharmaceutical Solutions employs approximately 96 people worldwide.

Does SEQENS Pharmaceutical Solutions own any subsidiaries ?

SEQENS Pharmaceutical Solutions presently has no subsidiaries across any sectors.

How many LinkedIn followers does SEQENS Pharmaceutical Solutions have ?

SEQENS Pharmaceutical Solutions's official LinkedIn profile has approximately 10,186 followers.

Does SEQENS Pharmaceutical Solutions have a Crunchbase profile ?

No, SEQENS Pharmaceutical Solutions does not have a profile on Crunchbase.

Does SEQENS Pharmaceutical Solutions have a LinkedIn profile ?

Yes, SEQENS Pharmaceutical Solutions maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/seqens-cdmo.

How many cybersecurity incidents has SEQENS Pharmaceutical Solutions experienced ?

As of August 25, 2026, Rankiteo reports that SEQENS Pharmaceutical Solutions has experienced 1 cybersecurity incidents.

How many peer or competitor companies does SEQENS Pharmaceutical Solutions have ?

SEQENS Pharmaceutical Solutions has an estimated 5,737 peer or competitor companies worldwide.

What types of cybersecurity incidents has SEQENS Pharmaceutical Solutions faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SPS

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

SEQENS Pharmaceutical Solutions Vendor Cyber Rating & Cyber Score

seqens.com

Add Your Compliance Badge

Mastering a wide range of technologies, Seqens provide their clients with custom manufacturing services as well as a broad portfolio of Active Pharmaceutical Ingredients (APIs) & intermediates. Seqens offer technical excellence, continuous improvement plans and innovative tailor-made solutions from a network of 4 R&D centers serving the Pharmaceutical market, 4 pilot units and 12 cGMP sites, including 6 cGMP multi-purposes manufacturing sites.

SPS A.I CyberSecurity Scoring

Scoring History

SPS

SEQENS Pharmaceutical Solutions CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

SEQENS Pharmaceutic...

Ransomware

100

8/2021

SI-553072525

Loading…

A.I.

SPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for SEQENS Pharmaceutical Solutions in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for SEQENS Pharmaceutical Solutions in 2026.

Incident Types SPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for SEQENS Pharmaceutical Solutions in 2026.

Incident History - SPS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

SEQENS Pharmaceutical Solutions Subsidiaries

SPS

Pharmaceutical Manufacturing

Website: https://cdmo.seqens.com

Company Size: 96

SEQENSPharmaceutical Manufacturing

SK Capital PartnersFinancial Services

Apotex Inc.Pharmaceutical Manufacturing

Apotex Pharmachem Inc.Pharmaceutical Manufacturing

ApobiologixBiotechnology Research

Apotex Inc. - QuébecPharmaceutical Manufacturing

ArchromaChemical Manufacturing

Color Atlas by ArchromaTextilherstellung

HeubachChemical Manufacturing

Ascend Performance MaterialsChemical Manufacturing

Acteev By AscendTextile Manufacturing

SI GroupChemical Manufacturing

Careers at SI GroupChemical Manufacturing

TPC GroupChemical Manufacturing

Valtris Specialty ChemicalsChemical Manufacturing

ChamplorFood and Beverage Manufacturing

Isolatek InternationalWholesale Building Materials

Tilley DistributionChemical Manufacturing

GEON Performance SolutionsPlastics Manufacturing

EcopolPackaging and Containers Manufacturing

Noramco™Pharmaceutical Manufacturing

Luxium SolutionsManufacturing

Lacerta Group, LLC.Packaging and Containers Manufacturing

DeltechChemical Manufacturing

INEOS CalabrianChemical Manufacturing

Woodstock Sterile SolutionsPharmaceutical Manufacturing

J&K IngredientsFood and Beverage Manufacturing

Foremark Performance ChemicalsChemical Manufacturing

Florachem CorporationChemical Manufacturing

VanDeMark Chemical IncChemical Manufacturing

CanlakChemical Manufacturing

SEQENS Personal CarePersonal Care Product Manufacturing

Loading…

SEQENS Pharmaceutical Solutions Similar Companies

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Loading…

NEWS

SEQENS Pharmaceutical Solutions CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 23, 2023 08:00 AM

Seqens’ Boston R&D Centre, Devens, Massachusetts, USA

Seqens has opened a $5m facility to develop and manufacture drugs and therapeutics in Devens, Massachusetts.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53532

SUMMARY

OpenEXR is the reference implementation and specification for the EXR image format, widely used in the motion picture industry. In versions 3.4.0 through 3.4.12, a crafted HTJ2K-compressed EXR file causes an unconditional process abort in any application that calls exr_start_read() on untrusted input, resulting in denial of service. The crash is triggered by a QCD marker whose lower five bits are zero, which OpenEXR passes into the vendored OpenJPH library while constructing the codestream and evaluating its quantization delta parameters. OpenJPH uses an assertion rather than a recoverable error to validate those bits, so any invalid value calls abort() directly and cannot be intercepted by surrounding error handling, a problem compounded by OpenEXR wrapping only its internal HT header parser in error handling while leaving the later codestream read and construction calls unprotected. This issue has been resolved in version 3.4.13.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: )

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-78435

SUMMARY

A vulnerability has been found in Faveo Helpdesk up to 2.0.3. Affected is the function unlink of the file app/Http/Controllers/Admin/helpdesk/SettingsController.php of the component Logo Handler. Such manipulation of the argument data1 leads to path traversal. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 3.8)

cvss2

Base Score: 4.7

Complexity: LOW

AV:N/AC:L/Au:M/C:N/I:P/A:P

cvss3

Base Score: 3.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

1.2

REFERENCES

CVE-2026-78434

SUMMARY

A flaw has been found in Faveo Helpdesk up to 2.0.3. This impacts the function FormController::post_ticket_reply of the file app/Http/Controllers/Client/helpdesk/FormController.php of the component post-ticket-reply Endpoint. This manipulation causes missing authentication. The attack can be initiated remotely. The exploit has been published and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 6.5)

cvss2

Base Score: 6.4

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:P

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-78284

SUMMARY

Unauthenticated Arbitrary File Deletion in MasterStudy LMS <= 3.7.42 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 8.6)

cvss3

Base Score: 8.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/masterstudy-lms-learning-management-system/vulnerability/wordpress-masterstudy-lms-plugin-3-7-42-arbitrary-file-deletion-vulnerability?_s_id=cve

CVE-2026-78282

SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Stripe Payments <= 2.1.2 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/stripe-payments/vulnerability/wordpress-stripe-payments-plugin-2-1-2-cross-site-scripting-xss-vulnerability?_s_id=cve

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…